With a focus on Therapeutics and Synthetic Biology, Codon Capital acts as an accelerator and virtual laboratory to bring together experts in these fields. Founded in 2013 by Karl Handelsman, the firm is based in San Francisco and aims to be at the forefront of the new biology design revolution, which will shape the future of healthcare and agriculture.